As a National Cancer Institute (NCI)-Designated Cancer Center, the Laura and Isaac Perlmutter Cancer Center at NYU Langone is committed to establishing and developing Research Programs aimed at understanding the origins of human cancer and in using this information to prevent and treat cancer and ease its burden on patients and their families. The Perlmutter Cancer Center is dedicated both to furthering scientific progress and to meeting the clinical needs of its patients. These two goals receive the full participation of both basic and clinical investigators, practicing physicians, and other healthcare providers.
Research Program Members are academic contributors who conduct cancer-focused basic laboratory investigations; correlative studies that link laboratory evaluation of human tumors with clinical outcomes; therapeutic protocols based on insights developed in the laboratory; population-based studies to determine risk and/or to assess approaches to prevention; and studies dedicated to understanding barriers to effective cancer care. In addition, Research Program Members are funded by the NCI or by NCI-approved peer-reviewed agencies or organizations.
Research Programs at the Perlmutter Cancer Center are either NCI Cancer Center Support Grant Programs (CCSG) or Disease Management Groups (DMG), but in some cases are both (* indicated below). These types of programs are linked, which enhances the quality of research at every level at the Perlmutter Cancer Center.
Cancer Center Support Grant (CCSG) Research Programs
A CCSG-funded Research Program comprises the activities of a group of investigators who share common scientific interests and goals and who participate in competitively funded research. Investigators in these programs interact with each other and with researchers elsewhere, which leads to an exchange of information, experimental techniques, and ideas which enhance their individual productivity. Ultimately, the success of Research Programs is measured by scientific excellence and by the emergence of productive collaborations and joint publications.
* Indicates an area of research within both CCSG and DMG
|Breast Cancer *||Genitourinary Cancer *|
|Cancer Immunology||Growth Control|
|Environmental & Molecular Carcinogenesis||Melanoma *|
|Epidemiology and Cancer Control||Stem Cell Biology|
Disease Management Groups
Disease Management Groups (DMGs) are critical to the research mission of the Perlmutter Cancer Center. They create bridges between medical disciplines and between areas of research devoted to specific types of cancer. Members of DMGs meet at least monthly to design and implement new clinical and translational research initiatives and investigator-initiated early phase trials, and to prioritize clinical protocols. These meetings also allow members to ensure the best multidisciplinary care for patients.
|Gastrointestinal Cancers||Pediatric Oncology|
|Gynecologic Oncology||Thoracic Oncology|
|Hematologic Malignancies||Thyroid and Endocrine Cancers|